Document Classification

Section Type: RESULTS

Text: The mean change at 96 weeks in hepatocellular ballooning scores was 0. 1 with placebo (95 % CI, -0. 2 to 0. 3) vs -0. 5 with vitamin E (95 % CI, -0. 8 to -0. 3 ; P =. 006) and -0. 3 with metformin (95 % CI, -0. 6 to -0. 0 ; P =. 04) ; and in NAFLD activity score, -0. 7 with placebo (95 % CI, -1. 3 to -0. 2) vs -1. 8 with vitamin E (95 % CI, -2. 4 to -1. 2 ; P =. 02) and -1. 1 with metformin (95 % CI, -1. 7 to -0. 5 ; P =. 25).